MedTrace Logo

Adipose Derived Cells for Chronic Obstructive Pulmonary Disease

NCT02041000 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-03-16

No results posted yet for this study

Summary

The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed with chronic obstructive pulmonary disease (COPD).

Conditions

Interventions

OTHER

Adipose Derived Stem Cells

Sponsors & Collaborators

  • Bioheart, Inc.

    lead INDUSTRY

Principal Investigators

  • Kristin Comella · Bioheart

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041000 on ClinicalTrials.gov